hanmail.net Background/aims To investigate the effect of peripapillary retinoschisis on the peripapillary retinal nerve fibre layer (RNFL) thickness measurement by using optical coherence tomography ...

In total, 30.8% of the eyes had a final vision ≥20/200. Conclusion: The presence of retinoschisis (retinal cyst) in Coats disease is strongly associated with retinal telangiectasia and exudation and ...

3 Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, People's Republic of China Aims Choroidal neovascularisation (CNV) in patients with X-linked retinoschisis (XLRS) has ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

After hours: February 20 at 4:21:36 PM EST Loading Chart for ABEO ...

ATSN-201 has received Orphan Drug and Rare Pediatric Disease designations from the U.S. Food and Drug Administration. About X-linked Retinoschisis (XLRS) XLRS is a monogenic X-linked disease caused by ...

Seeing flashing lights in the corner of one or both eyes can occur with migraine or result from trauma, detached retina, or other problems. The flashes of light may vary in shape, color, frequency ...

Emmanouil Angelakis; Esam I Azhar; Fehmida Bibi; Muhammad Yasir; Ahmed K Al-Ghamdi; Ahmad M Ashshi; Adel G Elshemi; Didier Raoult ...

For our lead preclinical program, for X-linked retinoschisis (XLRS), we are taking advantage of this capability and administering it using a para-retinal injection. This method is less invasive ...

The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...

The company’s lead program is evaluating ATSN-201 in an ongoing Phase I/II clinical trial for X-linked retinoschisis (XLRS), a genetic condition that is typically diagnosed in childhood and ...